THE ROLE OF SPASMOLYTIC THERAPY IN THERAPY OF CHRONIC CONSTIPATIONS AMONG CHILDREN
Abstract
The article grounds the application of the spasmolytic therapy in complex treatment of chronic constipations among children by the example of hyoscine butylbromide (buscopan, boehringer ingelheim pharma, germany). favourable impact of the medication on the motoraevacuation function of the large intestine has been proved both clinically and by means of functional and ultrasonic methods of the large intestine examination. Good tolerance of the medication allows for its application in pediatric practice.
Key words: children, chronic constipation, diagnostics, treatment, hyoscine butylbromide.
Key words: children, chronic constipation, diagnostics, treatment, hyoscine butylbromide.
About the Authors
A.S. Potapov
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
E.V. Komarova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A.V. Petrova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L.F. Podmarenkova
Scientific Center of Coloproctology, Federal Agency for Healthcare and Social Development, Moscow
Russian Federation
Russian Federation
I.V. Dvoriakovskiy
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Review
For citations:
Potapov A., Komarova E., Petrova A., Podmarenkova L., Dvoriakovskiy I. THE ROLE OF SPASMOLYTIC THERAPY IN THERAPY OF CHRONIC CONSTIPATIONS AMONG CHILDREN. Pediatric pharmacology. 2007;4(2):84-86.
Views:
564
Email this article 